| Thursday, November 7, 2002 |
|
6:45 - 7:45 am
|
Breakfast Symposium (Supported by an unrestricted
educational grant from Purdue Pharma)
Rational Use of Opioid Analgesics:
What have we learned and what are the promises for the future?
James P. Rathmell, MD
|
|
8:00 - 8:15 am
|
Welcome |
|
|
| |
Refresher Courses
|
Breakout with the Experts |
|
8:00 - 9:00 am
|
Peripheral
nerve blocks in chronic pain
Basic Science: James C. Eisenach, MD /
Clinical Aspects: Patricia M. Lavand'homme,
MD, PhD
|
Immediately following each lecture, you will have the
opportunity to meet in a small group with each speaker
|
|
9:00 - 10:00 am
|
Cancer Pain: Risks and benefits
of opioid therapy
Basic Science: Tony L. Yaksh, PhD /
Clinical Aspects: Stephen E. Abram, MD
|
|
|
10:00 - 11:00 am
|
Preemptive Analgesia: Current
status
Basic Science: Marshall Devor, PhD /
Clinical Aspects: Igor Kissin, MD
|
|
| 11:00 am - 12:00 pm |
Clinical Outcomes in Pain Medicine:
Using health-related quality-of-life surveys to capture pain-related health
status
Basic Science: Fredrick K. Orkin, MD, MBA,
MSc / Clinical Aspects: Alex Macario, MD
|
|
|
12:00 - 1:00 pm
|
PBLD Luncheons
PBL 1. Back Pain, Sunil J. Panchal, MD
PBL 2. Patient on opioid analgesics, Scott M. Fishman, MD
PBL 3. Painful diabetic neuropahty
(PDN), Mark S. Wallace, MD
PBL 4. Herpes zoster / postherpetic
neuralgia, Marc Huntoon, MD
|
|
Refresher Courses Continued
|
Breakout with the Experts Continued |
| 1:00 - 1:45 pm |
Radiofrequency procedures for
the treatment of painful disorders of the spine
Menno E.Sluijter, MD
|
|
|
1:45 - 2:30 pm
|
Neuromodulation in the treatment
of chronic pain
Allen Burton, MD
|
|
|
2:30 - 3:00 pm
|
Break |
|
3:00 - 3:45 pm
|
Celiac Plexus Block: Does early
intervention improve outcomes?
Daniel B. Carr, MD
|
|
| 3:45-4:30 pm |
Neuronal Plasticity and Signal
Transduction in Nociceptive Neurons: The role of COX2 in sensitization
of the nervous system following injury
Tarek Samad, PhD
|
|
|
4:30 - 6:30 pm
|
Pain Review
(Supported by an unrestricted educational grant from Pfizer)
Moderator: Gordon Irving, MD
Edgar L. Ross, MD; James P. Rathmell, MD
.
|
|
| |
|
|